Loading…

Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

In 2004 we described the E46K mutation in alpha-synuclein gene (E46K-SNCA), a rare point mutation causing an aggressive Lewy body disease with early prominent non-motor features and small fiber denervation of myocardium. Considering the potential interest of the skin as a target for the development...

Full description

Saved in:
Bibliographic Details
Published in:Parkinsonism & related disorders 2019-08, Vol.65, p.139-145
Main Authors: Carmona-Abellan, Mar, Gabilondo, Inigo, Murueta-Goyena, Ane, Khurana, Vikram, Tijero, Beatriz, Luquin, María Rosario, Acera, Marian, Del Pino, Rocío, Gardeazabal, Jesús, Martínez-Valbuena, Ivan, Sanchez-Pernaute, Rosario, Gómez-Esteban, Juan Carlos
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In 2004 we described the E46K mutation in alpha-synuclein gene (E46K-SNCA), a rare point mutation causing an aggressive Lewy body disease with early prominent non-motor features and small fiber denervation of myocardium. Considering the potential interest of the skin as a target for the development of biomarkers in Parkinson's Disease (PD), in this work we aimed to evaluate structural and functional integrity of small autonomic nerve fibers and phosphorylated alpha-synuclein (p-synuclein) deposition in the skin of E46K-SNCA carriers as compared to those observed in parkin gene mutation (PARK2) carriers and healthy controls. We studied 7 E46K-SNCA carriers (3 dementia with Lewy bodies, 2 pure autonomic failure, 1 PD and 1 asymptomatic), 2 PARK2 carriers and 2 healthy controls to quantify intraepidermal nerve fiber density and p-synuclein deposition with cervical skin punch biopsies (immunohistochemistry against anti PGP9.5/UCHL-1, TH and p-synuclein) and sudomotor function with electrochemical skin conductance (ESC) (SudoScan). All E46K-SNCA carriers had moderate to severe p-synuclein deposits and small fiber neurodegeneration in different epidermal and dermal structures including nerve fascicles and glands, especially in carriers with Pure Autonomic Failure, while p-synuclein aggregates where absent in healthy controls and in one of two PARK2 carriers. The severity of the latter skin abnormalities in E46K-SNCA were correlated with sudomotor dysfunction (lower ESC) in hands (p = 0.035). These results together with our previous findings support the relevance of E46K-SNCA mutation as a suitable model to study small fiber neuropathy in Lewy body diseases. •The E46K-SNCA mutation is of interest given the rarity of this mutation.•The results highlight the peculiarity of this mutation and reinforce the idea of peripheral tissue as a biomarker of the disease.•SNCA-E46K mutation is very rare, and the fact that synuclein is altered make this mutation unique as an in vivo model of disease progression.•There is a correlation between electroconductance and synuclein aggregates in these patients.•For the first time, we describe the presence of peripheral nervous system peculiarities, in patients with a wide spectrum of phenotype and the same genotype.
ISSN:1353-8020
1873-5126
DOI:10.1016/j.parkreldis.2019.05.038